Page last updated: 2024-12-08

5-hydroxypyrazinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxypyrazinamide: metabolite of pyrazinamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151823
CHEBI ID166571
SCHEMBL ID9681925
MeSH IDM0100582

Synonyms (21)

Synonym
6-oxo-1h-pyrazine-3-carboxamide
13924-96-4
CHEBI:166571
5-hydroxypyrazinamide
pyrazinecarboxamide, 4,5-dihydro-5-oxo-
AKOS006237904
SCHEMBL9681925
5-hydroxypyrazine-2-carboxamide ,
XENWQEOTDAQROM-UHFFFAOYSA-N
5-carbamoylpyrazin-2-one
DTXSID20160973
5-oxo-4,5-dihydropyrazine-2-carboxamide
mfcd19160577
5-hydroxy-(8ci)-pyrazinecarboxamide
5-hydroxypyrazinecarboxamide
J-007254
2-carboxamido-5-hydroxypyrazine
AS-30100
Q63395802
CS-0062145
SY241817
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyrazines
carboxamideAn amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (54.55)18.7374
1990's5 (45.45)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.78 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]